comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-30 22:05:22 - browse：68296

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： BMS, looking to build heart drug business, turns to AI for diagnosis

focus

entertainment

WSS

Biden administration begins canceling student loan debt for 804,000 borrowers

Smaller biotechs seek to piggyback on weight loss drug boom

Study on Amgen’s bispecific immunotherapy produces positive data

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Bird flu researchers hone in on Finland’s mink farms

Roche acquires Telavant from Roivant, adding experimental IBD treatment

hotspot

comprehensive

Wikipedia

Sports medicine is finally prioritizing gender equality

Montana youths win climate lawsuit against state for promoting fossil fuels

Novavax promises a turnaround & Lilly roils the obesity market

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

In Memoriam: Notable people who died in 2023

Patients, digital health players weigh in on FTC's data privacy plan

Novavax promises a turnaround & Lilly roils the obesity market

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Activists slam private health insurers over coverage restrictions

J&J lung cancer data amount to new salvo against AstraZeneca

hotspot

BMS, looking to build heart drug business, turns to AI for diagnosis

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

How AI can help patients find reliable information about doctors

UnitedHealth, Optum discontinue NaviHealth name

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

J&J lung cancer data amount to new salvo against AstraZeneca

focus

focus

entertainment

explore